GITR, Inc.
7Patents
7Active
7Granted
48Portfolio score
Filing activity: Jul 11, 2008 → Jun 28, 2018 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8591886B2 | Combination therapies employing GITR binding molecules | Chemistry; Metallurgy | 104 | Active |
| US8388967B2 | Methods for inducing or enhancing an immune response by administering agonistic GITR-binding antibodies | Emerging Cross-Sectional Technologies | 101 | Active |
| US9028823B2 | Methods of inducing or enhancing an immune response in a subject by administering agonistic GITR binding antibodies | Emerging Cross-Sectional Technologies | 22 | Active |
| US9241992B2 | Combination therapies employing GITR binding molecules | Chemistry; Metallurgy | 20 | Active |
| US9493572B2 | GITR antibodies and methods of inducing or enhancing an immune response | Emerging Cross-Sectional Technologies | 6 | Active |
| US10030074B2 | Methods of inducing or enhancing an immune response in a subject having cancer by administering GITR antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US10570209B2 | Methods for inducing or enhancing an immune response by administering agonistic glucocorticoid-induced TNFR-family-related receptor (GITR) antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.